• Cell Counting Kit-8 (CCK-8): Precision in Cell Viability Ana

  2026-06-02

  The Cell Counting Kit-8 (CCK-8) delivers unmatched sensitivity and simplicity for cell proliferation, viability, and cytotoxicity assays, outperforming traditional tetrazolium-based methods. Explore advanced experimental workflows, troubleshooting strategies, and real-world applications—anchored by breakthrough oncology research and APExBIO’s trusted reagent quality.

• PPARγ Activation Modulates Macrophage Polarization in IBD vi

  2026-06-02

  This study demonstrates that PPARγ activation, including via pioglitazone, orchestrates the shift from proinflammatory M1 to anti-inflammatory M2 macrophage phenotypes, attenuating DSS-induced inflammatory bowel disease in mice via STAT-1/STAT-6 pathways. These mechanistic insights advance the understanding of immune modulation in IBD and offer a robust foundation for translational research on macrophage-targeted therapies.

• Canagliflozin Hemihydrate in Glucose Metabolism Research Wor

  2026-06-01

  Canagliflozin hemihydrate empowers researchers to precisely dissect the renal glucose reabsorption pathway, offering reproducible, high-fidelity insights in diabetes and metabolic disorder studies. Its robust solubility and rigorously validated mechanism set it apart as an essential tool in advanced glucose metabolism research.

• DGLA-Induced Ferroptosis via ACSL4 in AML: Mechanistic Insig

  2026-06-01

  This study uncovers how exogenous dihomo-γ-linolenic acid (DGLA) induces ferroptosis in acute myeloid leukemia (AML) cells through ACSL4-mediated lipid metabolism reprogramming. The findings highlight a mechanistically distinct cell death pathway, suggesting new therapeutic avenues for overcoming apoptosis resistance in AML.

• NMDA Receptor-Dependent Maturation of PV Interneuron Synapse

  2026-05-31

  This study reveals that the maturation of GABAergic synaptic transmission from neocortical parvalbumin (PV) interneurons depends on NMDA receptor activity recruiting Cav2.1 channels. Genetic disruption of these pathways impairs GABA release, illuminating a mechanism possibly contributing to schizophrenia pathogenesis. The findings refine our understanding of inhibitory circuit development and provide mechanistic context for disease models.

• Entecavir (BMS200475): Molecular Precision in HBV Suppressio

  2026-05-30

  Explore how Entecavir, a potent inhibitor of hepatitis B virus replication, enables precise and long-term suppression of chronic HBV infection—even in resistant strains. This article uniquely analyzes molecular selectivity, resistance dynamics, and clinical translation, offering depth beyond standard reviews.

• Pol II Degradation Triggers Cell Death Beyond Loss of Transc

  2026-05-29

  This study demonstrates that targeted degradation of RNA polymerase II (Pol II) initiates cell death independently of transcriptional repression. The findings reframe our understanding of proteasome-regulated apoptosis and suggest new strategies for dissecting cell death pathways in cancer research.

• High-Throughput Discovery of Ionizable Lipids for mRNA Deliv

  2026-05-29

  Li et al. (2024) report a high-throughput synthesis and screening of 623 ionizable lipids (ILs) via A3 coupling, uncovering specific structural motifs that maximize mRNA delivery efficiency in lipid nanoparticles (LNPs). Their findings establish new structure–function guidelines for rational IL design in mRNA therapeutics and enable more effective gene regulation assays and in vivo imaging platforms.

• Rotenone and the Cellular Redox Network: Precision in Mitoch

  2026-05-28

  Explore how Rotenone, a mitochondrial Complex I inhibitor, uniquely bridges mitochondrial dysfunction modeling with redox signaling insight. This article offers advanced perspectives for autophagy pathway research and neurodegenerative disease models.

• HyperFluor™ 488 Goat Anti-Rabbit IgG: Practical Use Guide

  2026-05-28

  HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody provides sensitive, specific fluorescent detection of rabbit primary antibodies in immunofluorescence, flow cytometry, and microscopy workflows. It is not intended for non-rabbit primaries or applications incompatible with sodium azide. This guide details actionable parameters, QC steps, and troubleshooting for effective use.

• RIG-I Drives Renal Fibrosis via c-Myc in UUO Mouse Kidneys

  2026-05-27

  This study identifies RIG-I as a critical promoter of renal interstitial fibrosis through c-Myc-mediated fibroblast activation in mouse models of kidney injury. The findings reveal an inflammatory signaling axis linking tubular epithelial cells to fibroblast activation, offering mechanistic insights for chronic kidney disease research.

• FKBP9 Drives Glioblastoma Malignancy and ER Stress Resistanc

  2026-05-27

  Xu et al. (2020) reveal that FKBP9 promotes glioblastoma progression and uniquely confers resistance to endoplasmic reticulum (ER) stress inducers by modulating the IRE1α-XBP1 pathway. These findings offer mechanistic insights into ER stress adaptation and highlight FKBP9 as a potential therapeutic target in high-grade gliomas.

• Pioglitazone in Translational Immunometabolic Research: Beyo

  2026-05-26

  Discover how Pioglitazone, a selective PPARγ agonist, uniquely advances immunometabolic research beyond diabetes, with deep insights into macrophage polarization and inflammatory modulation. This article delivers new perspectives for translational and assay design strategies.

• Latrunculin B Inhibitor: Precision in Actin Cytoskeleton Dis

  2026-05-26

  Latrunculin B offers researchers transient, selective inhibition of actin filament assembly—enabling time-resolved studies of cytoskeletal organization and cellular actin dynamics. This guide translates mechanistic insights and experimental workflows into actionable protocols, highlighting APExBIO's Latrunculin B as a cornerstone for advanced cytoskeleton research.

• PPARγ Activation Modulates Macrophage Polarization in IBD

  2026-05-25

  This study demonstrates that PPARγ activation, notably through pioglitazone, orchestrates a shift in macrophage polarization, attenuating inflammatory bowel disease (IBD) via STAT-1/STAT-6 pathway modulation. The findings clarify the mechanistic basis for immune modulation in IBD and offer guidance for translational inflammation research.

16361 records 1/1091 page Next 12345 下5页 Last page